Implantable gastric stimulation for the treatment of severe obesity: the American experience

  • Shikora S
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The prevalence of obesity is growing worldwide at an alarming rate. Current medical therapies are often ineffective and surgical treatments result in weight loss but have significant risk. Implantable Gastric Stimulation (IGS) offers a novel approach to weight loss. Simply stated, the IGS system electrically stimulates the stomach with a pacemaker-like device. The device is implanted in a brief minimally invasive procedure. Investigation in over 500 patients globally has proven it to be safe and seemly free of long-term sequelae. With refinements in patient selection and device application, the weight loss results have been steadily improving. The IGS may someday become a reliable and safe surgical option for weight loss.

Author-supplied keywords

  • Gastric myo-electric stimulation
  • Implantable device
  • Morbid obesity
  • Obesity
  • Weight loss

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Scott A. Shikora

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free